# Accuray and China Isotope form joint venture for radiation oncology systems in China

Accuray Asia Limited and CNNC High Energy Equipment (Tianjin) Co., Ltd., a subsidiary of China Isotope and Radiation Corporation, formed a joint venture named CNNC Accuray (Tianjin) Medical Technology Co., Ltd. to manufacture and sell radiation oncology systems in China. CIRC's subsidiary will own 51% and Accuray's subsidiary 49%.

- Type: Partnership
- Announced: 2019-01-28
- Where: Tianjin, China, China
- Status: announced
- Products: radiation oncology systems, radiation therapy products
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Accuray](https://endata.com/companies/36923.md) (partner)
- [China Isotope and Radiation Corporation](https://endata.com/companies/36924.md) (partner)

## Sources

- [biopharmawatch.com](https://www.biopharmawatch.com/news/ARAY/accuray-and-china-isotope-and-radiation-corporation-enter-joint-venture-contract-to-manufa-aray-20190128), 2019-01-28: "Accuray and CIRC believe that the JV...will be uniquely positioned to serve the world's largest growth market for radiation oncology systems."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.